Oncodesign Precision Medicine (OPM) Announces its IPO Through Direct Listing on Euronext Access + Paris
Direct listing of OPM on Euronext Access Paris on 5 October 2022 Q&A available (only in French): click here Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63;